Clinical Trials Day is a special occasion for SCRS. This year, we took time to reflect on what being part of this important work means to us and the tremendous challenge that our industry overcame in 2020 and early 2021. When we stopped to think of truly inspiring and innovative progress that was made in spite of these challenges Pfizer was the first organization that came to mind. We had the opportunity to speak with Liz Rogers, Vice President and Head of Global Site and Study Operations and Sarah Tweedy, Vice President and Head of Vaccine Clinical Operations at Pfizer about what they think the future of research is and how their organization adapted and quickly became a household name in COVID-19 vaccine development.